Filing Details
- Accession Number:
- 0001209191-22-020153
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-18 20:01:07
- Reporting Period:
- 2022-03-16
- Accepted Time:
- 2022-03-18 20:01:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1661460 | Poseida Therapeutics Inc. | PSTX | Biological Products, (No Disgnostic Substances) (2836) | 472846548 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1816804 | D. Kerry Ingalls | C/O Poseida Therapeutics, Inc. 9390 Towne Centre Drive, Ste 200 San Diego CA 92121 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-03-16 | 3,000 | $3.98 | 55,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.965 to $3.98 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
